Sundstrøm S - Search Results

1

Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer.

Halvorsen TO, Herje M, Levin N, Bremnes RM, Brustugun OT, Fløtten Ø, Kaasa S, Sundstrøm S, Grønberg BH. Halvorsen TO, et al. Among authors: sundstrom s. Lung Cancer. 2016 Dec;102:9-14. doi: 10.1016/j.lungcan.2016.10.003. Epub 2016 Oct 15. Lung Cancer. 2016. PMID: 27987595

2

Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial.

Strøm HH, Bremnes RM, Sundstrøm SH, Helbekkmo N, Aasebø U. Strøm HH, et al. J Thorac Oncol. 2014 Jun;9(6):825-33. doi: 10.1097/JTO.0000000000000184. J Thorac Oncol. 2014. PMID: 24807158 Free PMC article. Clinical Trial.

3

How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial.

Strøm HH, Bremnes RM, Sundstrøm SH, Helbekkmo N, Aasebø U. Strøm HH, et al. Clin Lung Cancer. 2015 May;16(3):183-92. doi: 10.1016/j.cllc.2014.08.005. Epub 2014 Nov 13. Clin Lung Cancer. 2015. PMID: 25481662 Free article. Clinical Trial.

4

Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.

Valan CD, Slagsvold JE, Halvorsen TO, Herje M, Bremnes RM, Brunsvig PF, Brustugun OT, Fløtten Ø, Levin N, Sundstrøm SH, Grønberg BH. Valan CD, et al. Anticancer Res. 2018 Feb;38(2):871-876. doi: 10.21873/anticanres.12296. Anticancer Res. 2018. PMID: 29374714 Clinical Trial.

5

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.

Strøm HH, Bremnes RM, Sundstrøm SH, Helbekkmo N, Fløtten O, Aasebø U. Strøm HH, et al. Among authors: sundstrom sh. Br J Cancer. 2013 Sep 17;109(6):1467-75. doi: 10.1038/bjc.2013.466. Epub 2013 Aug 20. Br J Cancer. 2013. PMID: 23963145 Free PMC article. Clinical Trial.

6

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.

Bremnes RM, Sundstrom S, Aasebø U, Kaasa S, Hatlevoll R, Aamdal S; Norweigian Lung Cancer Study Group. Bremnes RM, et al. Among authors: sundstrom s. Lung Cancer. 2003 Mar;39(3):303-13. doi: 10.1016/s0169-5002(02)00508-1. Lung Cancer. 2003. PMID: 12609569 Clinical Trial.

7

Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).

Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S; Norwegian Lung Cancer Study Group. Sundstrøm S, et al. Lung Cancer. 2005 May;48(2):251-61. doi: 10.1016/j.lungcan.2004.10.016. Epub 2004 Dec 15. Lung Cancer. 2005. PMID: 15829326 Clinical Trial.

8

Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?

Sundstrøm S, Bremnes RM, Brunsvig P, Aasebø U, Kaasa S; Norwegian Lung Cancer Study Group. Sundstrøm S, et al. J Thorac Oncol. 2006 Oct;1(8):816-24. J Thorac Oncol. 2006. PMID: 17409965 Free article.

9

A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.

Grønberg BH, Bremnes RM, Aasebø U, Brunsvig P, Fløtten O, Amundsen T, von Plessen C, Wang M, Sundstrøm S; Norwegian Lung Cancer Study Group. Grønberg BH, et al. Among authors: sundstrom s. Lung Cancer. 2009 Jan;63(1):88-93. doi: 10.1016/j.lungcan.2008.04.003. Epub 2008 Jun 6. Lung Cancer. 2009. PMID: 18538889 Clinical Trial.

10

Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy.

Grønberg BH, Sundstrøm S, Kaasa S, Bremnes RM, Fløtten O, Amundsen T, Hjelde HH, Plessen Cv, Jordhøy M. Grønberg BH, et al. Among authors: sundstrom s. Eur J Cancer. 2010 Aug;46(12):2225-34. doi: 10.1016/j.ejca.2010.04.009. Epub 2010 May 12. Eur J Cancer. 2010. PMID: 20471248 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page